Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Haidopoulos

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 20, 2014
The work place educational climate in gynecological oncology fellowships across Europe: the impact of accreditationJurgen Piek, Michaela Bossart, Klarke Boor, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2023
Thoracic epidural analgesia as part of an enhanced recovery program in gynecologic oncology: a prospective cohort studyAnastasios Pandraklakis, Dimitrios Haidopoulos, Theodoros Lappas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 15, 2018
Incidence of Lymph Node Metastases in Women With Low-Risk Early Cervical Cancer (<2 cm) Without Lymph-Vascular InvasionLucas Minig, Anna Fagotti, Giovanni Scambia, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 13, 2024
Chemotherapy response score as a predictor of survival in ovarian cancer patientsIoannis Rodolakis, Michalis Liontos, Vasilios Pergialiotis, et al.
Cancers|July 14, 2023
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian CancerAngeliki Andrikopoulou, Charalampos Theofanakis, Christos Markellos, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of ExperienceMichalis Liontos, Anna Svarna, Charalampos Theofanakis, et al.
Journal of Clinical Medicine|December 30, 2025
Indications and Limitations of vNOTES for the Surgical Staging of Early-Stage Ovarian Cancer: A Narrative Literature ReviewVasilios Lygizos, Dimitrios Efthymios Vlachos, Dimitrios Haidopoulos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 24, 2017
Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology TraineesCarmen Gan, Michaela Bossart, Jurgen Piek, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor ExpressionAnna Svarna, Michalis Liontos, Kallirroi Goula, et al.
International Journal of Cancer|March 30, 2011
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2Apostolos C Ziogas, Nikos G Gavalas, Marinos Tsiatas, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 20, 2014
The work place educational climate in gynecological oncology fellowships across Europe: the impact of accreditationJurgen Piek, Michaela Bossart, Klarke Boor, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2023
Thoracic epidural analgesia as part of an enhanced recovery program in gynecologic oncology: a prospective cohort studyAnastasios Pandraklakis, Dimitrios Haidopoulos, Theodoros Lappas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 15, 2018
Incidence of Lymph Node Metastases in Women With Low-Risk Early Cervical Cancer (<2 cm) Without Lymph-Vascular InvasionLucas Minig, Anna Fagotti, Giovanni Scambia, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 13, 2024
Chemotherapy response score as a predictor of survival in ovarian cancer patientsIoannis Rodolakis, Michalis Liontos, Vasilios Pergialiotis, et al.
Cancers|July 14, 2023
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian CancerAngeliki Andrikopoulou, Charalampos Theofanakis, Christos Markellos, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of ExperienceMichalis Liontos, Anna Svarna, Charalampos Theofanakis, et al.
Journal of Clinical Medicine|December 30, 2025
Indications and Limitations of vNOTES for the Surgical Staging of Early-Stage Ovarian Cancer: A Narrative Literature ReviewVasilios Lygizos, Dimitrios Efthymios Vlachos, Dimitrios Haidopoulos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 24, 2017
Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology TraineesCarmen Gan, Michaela Bossart, Jurgen Piek, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor ExpressionAnna Svarna, Michalis Liontos, Kallirroi Goula, et al.
International Journal of Cancer|March 30, 2011
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2Apostolos C Ziogas, Nikos G Gavalas, Marinos Tsiatas, et al.
Pageof 13